PAK4 and breast carcinoma: Consistently, PAK4 overexpression is correlated with poor patient outcome in breast cancer patients, and its overexpression in cancer cell lines was shown to increase cell survival, anchorage-independent growth, cell migration, and invasion12,13,16–18.